HOME >> MEDICINE >> NEWS
Diagnosis of rhinitis and atopical dermatitis

This was the conclusion of Ana Mara Irujo Andueza in her PhD thesis defended recently at the Public University of Navarra.

8,607 children in 66 centres

The most common atopical illnesses in infancy are, besides asthma, atopical dermatitis and allergic rhinitis. Studies of a multicentre nature have shown a significant rise in these ailments throughout the world and the causes of the increase are, as yet, not sufficiently clear.

Within this context, the aim of the PhD thesis was to evaluate the prevalence of allergic rhinitis and atopical dermatitis amongst the school population in the area around Pamplona, the capital of Navarre, using parameters as sex, language, date of birth and school. The data obtained was compared with a previous study undertaken in 1994 in the same geographical zone, and against those carried out at other centres at a national and international level as part of the third phase of the International Study of Asthma and Allergies in Childhood (ISAAC).

In 2001 Ana Mara Irujo carried out a transversal epidemiological study - using questions from the ISAAC on two populations of children, a group between 6- and 7- year-olds and another between 12 and 14, both groups being drawn from 66 schools and colleges, mostly in the Pamplona-Irunea city area but also from centres in Baraain, Zizur Mayor, Zizur Menor, Atarrabia, Huarte, Burlada and Mutilva Baja.

The first signs of asthma

Rhinitis and atopical dermatitis are considered to be "the first signs of asthma". The expression "allergic triad" is used to refer to dermatitis followed by rhinitis and ending up with asthma. The rhinitis is characterised by an increase in nasal secretion, also normally associated with conjunctival factors of the eyes that significantly affect the quality of life, given that exercise and physical activity in general are affected.

According to the study, for the group of 6- and 7-year olds, the current fr
'"/>

Contact: Garazi Andonegi
garazi@elhuyar.com
34-94-336-3040
Elhuyar Fundazioa
7-Oct-2005


Page: 1 2 3

Related medicine news :

1. Diagnosis and referrals for kidney disease fall well short of need, Johns Hopkins study shows
2. Diagnosis and treatment of osteoporosis falls shortnon adherence compounds issue
3. Allergic rhinitis associated with impaired sleep quality
4. Tobacco smoke linked to allergic rhinitis in infants

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Diagnosis rhinitis and atopical dermatitis

(Date:8/28/2015)... ... ... As reported by Medical Daily on August 22 , Cellfina, a ... for two years, the longest of any cellulite reduction system currently on the market. ... effective solution for their cellulite, according to Dr. Robert Weiss, director of the premier ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... abuse, or those who might personally be struggling with chemical dependency, may be ... from Best Drug Rehabilitation, a results-driven holistic treatment center for addiction located in ...
(Date:8/28/2015)... ... August 28, 2015 , ... Altima Technologies, Inc., the maker ... data center assets and audio-video devices, recently released Visio Stencils for the following ... ProLiant Gen9, EMC VNX Series , Super Micro Computer SuperStorage, Hitachi Data Systems ...
(Date:8/28/2015)... ... 28, 2015 , ... The Nashville Business Journal recently announced ... business. Mr. Troy Mizell, Chairman of the Board at MyGenetx, is one ... Veterans Awards will recognize Nashville military veterans who, through their professional and personal ...
(Date:8/28/2015)... Arizona (PRWEB) , ... August 28, 2015 , ... ... and increased patient loyalty at a low cost. Personalized with practice contact information ... and existing patients. Dental offices can also incorporate Calendars into seasonal mailings, thank ...
Breaking Medicine News(10 mins):Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 3Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 2Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 3Health News:MyGenetx Board Member Receives Veterans Award 2Health News:SmartPractice® Introduces 2016 Calendars for Dental Practice Giveaways 2
(Date:8/28/2015)... Research and Markets ... the "Investigation Report on China,s Quetiapine Market, ... Developed by AstraZeneca plc, quetiapine (under the trade ... the treatment of schizophrenia. Approved by CFDA to ... the Catalogue of Drugs for the Basic National ...
(Date:8/28/2015)... 28, 2015 Research and ... the "Investigation Report on China,s Ranibizumab Market, 2012-2019" ... Novartis, ranibizumab was approved by CFDA to treat wet ... Lucentis, a product of Novartis, is available in the ... self- developed drug for the treatment of wet AMD ...
(Date:8/28/2015)... Perrigo Company plc ("Perrigo") (NYSE: PRGO ... (NASDAQ: MYL ) shareholder vote regarding its planned ... of Mylan,s offer to Perrigo shareholders have always been, ... careful reflection of the value available to Perrigo shareholders, ... Mylan has allowed its shareholders to consider," said ...
Breaking Medicine Technology:China Quetiapine Market Investigation Report 2010-2019 2Investigation Report on China's Ranibizumab Market, 2012-2019 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5
Cached News: